Table 1.
Indication | Pediatric | Adult | Total |
---|---|---|---|
Cirrhosis | 40 (12.0%) | 282 (42.3%) | 322 (32.2%) |
Biliary Atresia | 178 (53.3%) | 1 (0.2%) | 179 (17.9%) |
Primary biliary cirrhosis | 0 | 161 (24.2%) | 161 (16.1%) |
Inborn errors | 63 (18.9%) | 35 (5.3%) | 98 (9.8%) |
Sclerosing cholangitis | 1 (0.3%) | 81 (12.2%) | 82 (8.2%) |
Primary liver tumors | 4 (1.2%) | 38 (5.7%) | 42 (4.2%) |
Fulminant hepatic failure | 13 (3.9%) | 27 (4.1%) | 40 (4.0%) |
Secondary biliary cirrhosis | 7 (2.1%) | 13 (2.0%) | 20 (2.0%) |
Familial cholestasis | 15 (4.5%) | 0 | 15 (1.5%) |
Budd-Chiari syndrome | 2 (0.6%) | 13 (2.0%) | 15 (1.5%) |
Congenital hepatic fibrosis | 7 (2.1%) | 1 (0.2%) | 8 (0.8%) |